
Novartis bets on bigger blockbusters to power growth, forecasting 5% annual sales through 2031
来源:CNBC发布于 2026-11-19
Ahead of its Capital Markets Day on Thursday, Novartis upgraded its peak sales outlook for three of its blockbuster drugs to a combined $18 billion, up from a previous forecast of a combined $14 billi...
相关标的:NVS
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。